Compound febantel chewable tablet for dogs and cats

A technology of non-bantyr and chewable tablets, applied in the field of compound non-bantyr chewable tablets and its preparation, to achieve the effects of improving oral bioavailability, increasing compliance, and good taste

Inactive Publication Date: 2013-05-08
QINGDAO VLAND BIOTECH INC
View PDF0 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Changshanone is a new broad-spectrum anticoccidial drug, no adverse reactions have

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0017] Prescription composition:

[0018] Febantyr 10mg

[0019] Praziquantel 5mg

[0020] Pyrantel 15mg

[0021] Hemosanone 5mg

[0022] Microcrystalline Cellulose 23mg

[0023] Starch 30mg

[0024] Magnesium Stearate 2mg

[0025] Beef Flavor 10mg

[0026] Total 100mg per tablet

[0027] Preparation method: praziquantel, pyrantel, febantyle, hemosanone, microcrystalline cellulose, and starch are respectively passed through a 100-mesh sieve, mixed evenly, made into a soft material with an appropriate amount of alcohol, granulated with a 20-mesh sieve, dried, and 20-mesh Sieve whole grains, add beef essence and magnesium stearate, mix well, and press into tablets to obtain.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a compound febantel chewable tablet for dogs and cats. The active ingredients of the chewable tablet include praziquantel, pyrantel, febantel and halofuginone. The chewable tablet overcomes the characteristic of poor palatability of traditional tablets, can enable dogs and cats to chew drugs fully, and can ensure that the drugs are fully absorbed and good efficacy can be brought into play. The tablet provided in the invention comprises, by mass: 10%-20% of febantel, 5%-10% of praziquantel, 15%-25% of pyrantel, 5%-10% of halofuginone, 30%-50% of a filling agent, 0.5%-3% of a binder, and 5%-15% of a flavoring agent. The preparation process of the chewable tablet provided in the invention is simple, and can prepare the product with good taste and stable quality, thus being suitable for industrialized production.

Description

technical field [0001] The invention relates to a compound febantyr chewable tablet for expelling nematodes, tapeworms and protozoa in dogs and cats and a preparation method thereof. Background technique [0002] At present, there are many medicines for treating nematodes and tapeworms in dogs and cats in the pet market, but due to the serious mixed feeling of parasites in pets, there is currently a lack of antiparasitic medicines on the market that can treat nematodes, tapeworms and protozoa at the same time. Therefore, we have developed a highly efficient, comprehensive and safe antiparasitic drug. Its main ingredients include Praziquantel, Pyrantel, Febental and Halofuginone. Praziquantel is clinically effective against Schistosomiasis japonicum, Taeniasis, Clonorchiasis, and Paragonimiasis. Pyrantel is mainly used clinically to drive away roundworms, hookworms, and pinworms. Febantyr is a benzimidazole precursor anthelmintic, which has been approved in the United Sta...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K31/517A61K31/506A61K31/4985A61K31/27A61K9/20A61P33/00A61P33/02
Inventor 郝智慧张瑞丽王艳玲
Owner QINGDAO VLAND BIOTECH INC
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap